J. Safra Sarasin Holding AG Acquires 3,163 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

J. Safra Sarasin Holding AG grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 20.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,406 shares of the healthcare conglomerate’s stock after acquiring an additional 3,163 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in UnitedHealth Group were worth $9,311,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $28,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Promus Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday, January 10th. Barclays cut their price objective on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research report on Monday. KeyCorp reduced their price objective on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating on the stock in a research report on Monday. Finally, Mizuho increased their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and four have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $615.24.

UnitedHealth Group Stock Performance

NYSE UNH opened at $425.39 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $424.81 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $389.11 billion, a PE ratio of 27.44, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a fifty day moving average of $510.91 and a two-hundred day moving average of $538.77.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.97%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.